CRYL1 and metabolic dysfunction-associated steatotic liver disease: As to CRY2, we think however that CRY activation could be hazardous: our SNP data suggest that any supra-physiological enhancement of CRY2 signaling may favor liver fat accumulation and, thus, promote non-alcoholic fatty liver disease and type-2 diabetes.